Francois Binette - Jul 22, 2022 Form 3/A Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role
COO and Executive VP for R&D
Signature
/s/ Francois Binette
Stock symbol
RENB
Transactions as of
Jul 22, 2022
Transactions value $
$0
Form type
3/A
Date filed
2/16/2024, 09:38 AM
Date Of Original Report
Aug 18, 2022
Next filing
Oct 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RENB Option to purchase shares of Common Stock Jul 22, 2022 Common Stock 65K $8.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was inadvertently omitted from the reporting person's original Form 3, and from the Form 4 filed by the reporting person after his original Form 3 was filed.